Discovery on Target 2026 has ended. This guide stays up as the record of who was there. Next: Discovery on Target 2027, Oct 18–21, 2027 in Boston

Actithera at Discovery on Target 2026

Sep 28 – Oct 1, 2026 Boston, MA ~1.1k attendees Website

Actithera brings 2 presentations to Discovery on Target 2026 in Boston. Its program centres on radioligand therapies, including covalent ligands as an emerging way to optimize them. It also weighs what will define the next generation, from molecular design to clinical success.

OrganizationDiscovery on Target 2026 Attendance
Actithera
Cambridge, MA
actithera.com
Biotech
Radiopharmaceutical company designing targeted molecules that carry radioactive isotopes to tumors.
Talk
Tue Sep 29
10:35am–11:05am
Covalent Ligands in RLTs: An Emerging Approach to Optimizing Therapy
Radioligand Therapies
Panel
Tue Sep 29
11:05am–12:05pm
Defining Next-Generation Radioligand Therapies: From Molecular Design to Clinical and Commercial Success
Radioligand Therapies · with Normunity, Lumina Pharmaceuticals, Ratio Therapeutics +2 more

Explore the full Discovery on Target 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full Discovery on Target 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Actithera

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Discovery on Target or its organizers. Submit a correction